Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplements Part Of The Past As Perrigo Frames Future Around Rejecting Mylan Tender

This article was originally published in The Tan Sheet

Executive Summary

The OTC private label leader says its supplement business will be the first asset it sells as it begins a streamlining process, which also includes supply chain consolidation and staff reductions, aimed at $35m in annual cost savings.


Related Content

Perrigo Shareholder Lawsuits Claim Joining Mylan Was A Better Idea


Related Companies

Related Deals

What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts